DG
Deepika Goyal
About Deepika Goyal
Data last updated:
Deepika Goyal is a Director at Medicea Pharmaceutical Private Limited (since 2023) and Director at Abhedam Builders And Promoters Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Medicea Pharmaceutical Private Limited at ₹8.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medicea Pharmaceutical Private Limited U21002PB2023PTC058162 | Director | 13 Apr 2023 | 2023 | ₹8.7 Lakh (FY 2025) | Active |
| Abhedam Builders And Promoters Private Limited U68200PB2025PTC064683 | Director | 26 May 2025 | 2025 | Active |
Board colleagues of Deepika Goyal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Goyal | 10236718 | Medicea Pharmaceutical Private Limited , Abhedam Builders And Promoters Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepika Goyal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepika Goyal
Deepika Goyal currently holds 2 directorships: Medicea Pharmaceutical Private Limited (Director, since 13 Apr 2023, revenue ₹8.7 Lakh (FY 2025)); Abhedam Builders And Promoters Private Limited (Director, since 26 May 2025).
Deepika Goyal was first appointed on 13 Apr 2023 as Director at Medicea Pharmaceutical Private Limited. The most recent appointment on record is 26 May 2025 at Abhedam Builders And Promoters Private Limited.
The current boards of Deepika Goyal's companies include Amit Kumar Goyal (Medicea Pharmaceutical Private Limited).